SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

G

GEHC

GE HealthCare Technologies Inc.

$74.27

-2.84 (-3.68%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$74.27

Live market price

P/E (TTM)

16.29

EPS: $4.56

P/S (TTM)

1.64

Price to Sales

TTM Quarters

4

Quarters included in TTM

Updated: 3/8/2026, 5:56:36 AM

Historical Trends

Range:

Revenue Over Time

Q1 2023Q4 2023Q3 2024Q4 2025$0B$2B$4B$6B$8B

Net Income Over Time

Q1 2023Q4 2023Q3 2024Q4 2025$0B$0B$0B$1B$1B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

10.0M

% of Float

2.2%

Days to Cover

2.4

Avg Daily Vol

4.2M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.96

Leverage ratio

ROE (TTM)

20.73%

Return on equity

Income Statement

Revenue

$20.63B


Cost of Revenue

$12.38B


Gross Profit

$8.25B


Operating Income

$2.76B


Net Income

$2.15B


EPS (Quarter)

$4.55


EPS (TTM)

--

Balance Sheet

Total Assets

$36.91B


Total Liabilities

$26.31B


Shareholders' Equity

$10.39B


Current Assets

$12.50B


Current Liabilities

$9.11B


Cash & Equivalents

--


Long-Term Debt

$10.00B

Cash Flow

Operating Cash Flow

$1.99B


Investing Cash Flow

$-1.05B


Financing Cash Flow

$617.00M


Free Cash Flow

$940.00M

Profitability Margins

Gross Margin

39.99%

Operating Margin

13.40%

Net Profit Margin

10.44%


ROA (TTM)

5.84%


ROE (TTM)

20.73%

Data source: Polygon.io

Last updated: 3/8/2026, 5:56:36 AM

Company Profile

Symbol

GEHC


Market Cap

$33.85B


IPO Date

Dec 15, 2022


CEO

--


Employees

54,000


Sector

--


Industry

X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS


Country

United States


Exchange

--

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Read More
SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy